909 related articles for article (PubMed ID: 9589675)
1. Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy.
Christopher M; Hew FL; Oakley M; Rantzau C; Alford F
J Clin Endocrinol Metab; 1998 May; 83(5):1668-81. PubMed ID: 9589675
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance in growth hormone-deficient adults: defects in glucose utilization and glycogen synthase activity.
Hew FL; Koschmann M; Christopher M; Rantzau C; Vaag A; Ward G; Beck-Nielsen H; Alford F
J Clin Endocrinol Metab; 1996 Feb; 81(2):555-64. PubMed ID: 8636267
[TBL] [Abstract][Full Text] [Related]
3. Insulin sensitivity in growth hormone (GH)-deficient adults and effect of GH replacement therapy.
Alford FP; Hew FL; Christopher MC; Rantzau C
J Endocrinol Invest; 1999; 22(5 Suppl):28-32. PubMed ID: 10442567
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle.
Bramnert M; Segerlantz M; Laurila E; Daugaard JR; Manhem P; Groop L
J Clin Endocrinol Metab; 2003 Apr; 88(4):1455-63. PubMed ID: 12679422
[TBL] [Abstract][Full Text] [Related]
5. The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation.
Lo JC; Mulligan K; Noor MA; Schwarz JM; Halvorsen RA; Grunfeld C; Schambelan M
J Clin Endocrinol Metab; 2001 Aug; 86(8):3480-7. PubMed ID: 11502767
[TBL] [Abstract][Full Text] [Related]
6. Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults.
Svensson J; Fowelin J; Landin K; Bengtsson BA; Johansson JO
J Clin Endocrinol Metab; 2002 May; 87(5):2121-7. PubMed ID: 11994351
[TBL] [Abstract][Full Text] [Related]
7. Insulin secretion in growth hormone-deficient adults: effects of 24 months' therapy and five days' acute withdrawal of recombinant human growth hormone.
Kamarudin N; Hew FL; Christopher M; Alford J; Rantzau C; Ward G; Alford F
Metabolism; 1999 Nov; 48(11):1387-96. PubMed ID: 10582546
[TBL] [Abstract][Full Text] [Related]
8. [Effect of recombinant human growth hormone on glucose metabolism in children with growth hormone deficiency].
Liang L; Zou CC; Li Y; Wang CL; Jiang YJ; Dong GP; Fu JF; Wang XM
Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):657-61. PubMed ID: 17217656
[TBL] [Abstract][Full Text] [Related]
9. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
Amato G; Mazziotti G; Di Somma C; Lalli E; De Felice G; Conte M; Rotondi M; Pietrosante M; Lombardi G; Bellastella A; Carella C; Colao A
J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
[TBL] [Abstract][Full Text] [Related]
10. Effect of growth hormone (GH) on glycerol and free fatty acid metabolism during exhaustive exercise in GH-deficient adults.
Gibney J; Healy ML; Stolinski M; Bowes SB; Pentecost C; Breen L; McMillan C; Russell-Jones DL; Sonksen PH; Umpleby AM
J Clin Endocrinol Metab; 2003 Apr; 88(4):1792-7. PubMed ID: 12679475
[TBL] [Abstract][Full Text] [Related]
11. Long-term monitoring of insulin sensitivity in growth hormone-deficient adults on substitutive recombinant human growth hormone therapy.
Giavoli C; Porretti S; Ronchi CL; Cappiello V; Ferrante E; Orsi E; Arosio M; Beck-Peccoz P
Metabolism; 2004 Jun; 53(6):740-3. PubMed ID: 15164321
[TBL] [Abstract][Full Text] [Related]
12. Different effects of short- and long-term recombinant hGH administration on ghrelin and adiponectin levels in GH-deficient adults.
Giavoli C; Cappiello V; Corbetta S; Ronchi CL; Morpurgo PS; Ferrante E; Beck-Peccoz P; Spada A
Clin Endocrinol (Oxf); 2004 Jul; 61(1):81-7. PubMed ID: 15212648
[TBL] [Abstract][Full Text] [Related]
13. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
[TBL] [Abstract][Full Text] [Related]
14. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: differential effects on protein, glucose, lipid, and calcium metabolism.
Mauras N; O'Brien KO; Welch S; Rini A; Helgeson K; Vieira NE; Yergey AL
J Clin Endocrinol Metab; 2000 Apr; 85(4):1686-94. PubMed ID: 10770216
[TBL] [Abstract][Full Text] [Related]
16. The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy.
Rosenfalck AM; Fisker S; Hilsted J; Dinesen B; Vølund A; Jørgensen JO; Christiansen JS; Madsbad S
Growth Horm IGF Res; 1999 Apr; 9(2):96-105. PubMed ID: 10373342
[TBL] [Abstract][Full Text] [Related]
17. The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults.
Rosenfalck AM; Maghsoudi S; Fisker S; Jørgensen JO; Christiansen JS; Hilsted J; Vølund AA; Madsbad S
J Clin Endocrinol Metab; 2000 Nov; 85(11):4173-81. PubMed ID: 11095450
[TBL] [Abstract][Full Text] [Related]
18. Metabolic profile in growth hormone-deficient (GHD) adults after long-term recombinant human growth hormone (rhGH) therapy.
Claessen KM; Appelman-Dijkstra NM; Adoptie DM; Roelfsema F; Smit JW; Biermasz NR; Pereira AM
J Clin Endocrinol Metab; 2013 Jan; 98(1):352-61. PubMed ID: 23162104
[TBL] [Abstract][Full Text] [Related]
19. Expression of insulin target genes in skeletal muscle and adipose tissue in adult patients with growth hormone deficiency: effect of one year recombinant human growth hormone therapy.
Khalfallah Y; Sassolas G; Borson-Chazot F; Vega N; Vidal H
J Endocrinol; 2001 Nov; 171(2):285-92. PubMed ID: 11691648
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
